참고문헌 (16)

1. Cancer. Res. J. Carmichael 47 936 1987 Carmichael, J., deGraff, W.G., Gazdar, A.F., Minna, J.D. and Mitchel, J.B., Evaluation of a tetrazolium-based semiautomated colorimetric assay; assessment of radiosenstivity.Cancer. Res., 47, 936-942 (1987). 

   상세보기

2. Cancer. Chemother. Rep. R. I. Geran 3 part III 1 1972 Geran, R. I., Greenberg, N.H., Macdonald, M.M., Schmacher, A.M. and Abott, B.J., Protocols for screeinig, chemical agents and natural products against animal tumors and other biological systems.Cancer. Chemother. Rep., part III 3, 1 (1972). 

3. Cancer. Treat. Rep. F.A. Greco 62 1407 1978 Greco, F.A., Richardson, R.L., Shulman and Oldmam, R.K., Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin-C and vincristine in advanced colorectal carcinoma.Cancer. Treat. Rep., 62, 1407-1412 (1978). 

   상세보기

4. J. Med. Chem. C.R. Hutchison 32 936 1989 Hutchison, C.R., Drug discovery and development through the genetic engineering of antibiotic-producing microorganisms.J. Med. Chem., 32, 936-937 (1989). 

5. J. Wonju Coll. Med. S.K. Kim 6 1 174 1993 Kim, S.K. and Koh, C.M.,In vivo antitumor activity and toxicological study of SK-302B.J. Wonju Coll. Med., 6(1), 174 (1993). 

6. J. Kor. Cancer. Ass. S.K. Kim 27 5 703 1995 Kim, S.K., Shin, W.S., Park, Y.S. and Choi, S.J.,In vitro chemosensitivity test fo SK-302B on human gastric carcinom, cell lines.J. Kor. Cancer. Ass., 27(5), 703-710 (1995). 

7. J. Kor. Soc. Microbiol. C.M. Koh 29 3 295 1994 Koh, C.M., Shin, W.S., Kim, S.K., Park, Y.S. and Park, J.Y., Antitumor activity of tumor cell growth inhibitory factor isolated fromStreptomyces sp.J. Kor. Soc. Microbiol., 29(3), 295-300 (1994). 

8. J. Kor. Colo. Proctol. Soc. N.K. Lee 6 92 1990 Lee, N.K. and Jun, K.Y., A clinical study of colorectal cancer.J. Kor. Colo. Proctol. Soc., 6, 92-98 (1990). 

9. J. Kor. Cancer Ass. Ministry of Health and Social Affairs 21 1 155 1989 Ministry of Health and Social Affairs, Five years report for cancer register program in the republic of Korea (1982.7.1-1989. 6.30).J. Kor. Cancer Ass., 21(1), 155-217 (1989). 

10. J. Natl. Cancer Inst. M.S. Mitchell 80 1445 1989 10.1093/jnci/80.18.1445 Mitchell, M.S., Combining chemotherapy with biological response modifiers in treatment of cancer.J. Natl. Cancer Inst., 80, 1445-1450 (1989). 

    상세보기

11. N. Engl. J. Med. S.E. Salmon 298 1321 1978 10.1056/NEJM197806152982401 Salmon, S.E., Hamberger, A.W., Soehnlen, B., Durie, B.G.M., Alberts, D.S. and Moon, T.E., Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs.N. Engl. J. Med., 298, 1321-1329 (1978). 

    상세보기

12. Stem cells R.H. Shoemaker 1 321 1981 Shoemaker, R.H., Igel, H.J., McLachlan, S.S. and Harfiel, J.L., Measurement of tumor colony growth and drug sensitivity in soft agarose culture using a ratio isotope method.Stem cells 1, 321-327 (1981). 

13. Cancer. Treat Rep. J.M. Venditti 67 767 1983 Venditti, J.M., The National Cancer Institute antitumor drug discovery program. current and future perspectives: a commentary.Cancer. Treat Rep., 67, 767-772 (1983). 

    상세보기

14. Am. J. Med. D.D. Hoff Von 70 1027 1981 10.1016/0002-9343(81)90859-7 Von Hoff, D.D., Casper, J. and Bradely, E., Association between human tumor colony assay results and response of an individual patient's tumor to chemotherapy.Am. J. Med., 70, 1027-1032 (1981). 

    상세보기

15. Cancer Chemother. Pharmacol. S. Wadler 34 3 266 1994 10.1007/BF00685088 Wadler, S., Tenteromano, L., Cazenave, L., Sparano, J. A. and Greenwald, E.S., Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer.Cancer Chemother. Pharmacol., 34(3), 266-269 (1994). 

    상세보기

16. Cancer Chemother. Rep. C.G. Zubrod 50 349 1966 Zubrod, C.G., The chemotherapy program of the National Cancer Institute: History, analysis and plans.Cancer Chemother. Rep., 50, 349-540 (1966). 

저자의 다른 논문 :

김수기 (25) 안찬묵 (8) 김태우 (33) 최선주 (15) 고춘명 (44)